LUNR vs MDA

LUNR exhibits severe fundamental distress, highlighted by a critical Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -3.92. While the stock has experienced a speculative price surge, the underlying financials show declining revenue growth (-18.10% YoY) and deep operating losses. The absence of a Graham Number or Altman Z-Score reflects a balance sheet that cannot support traditional valuation models. With heavy insider selling and a technical trend turning bearish, the current price appears decoupled from intrinsic value.

MDA exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and operational efficiency. The stock is trading at a significant premium, with a current price of $29.10 far exceeding both the Graham Number ($10.37) and the growth-based Intrinsic Value ($5.64). While recent Q/Q revenue growth of 44% shows short-term momentum, the stagnant YoY revenue growth (0.20%) and thin profit margins (2.24%) fail to justify the high P/E ratio of 46.94. The combination of a bearish technical trend and poor deterministic scores suggests a high risk of price correction.